Old Web
English
Sign In
Acemap
>
authorDetail
>
William Michael Seganish
William Michael Seganish
Merck & Co.
Biology
Kinase
Chemistry
IRAK4
Virology
4
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors.
2016
Bioorganic & Medicinal Chemistry Letters
Jennifer Hanisak
William Michael Seganish
William T. McElroy
Huadong Tang
Rumin Zhang
H.C. Tsui
Thierry O. Fischmann
Deen Tulshian
Jim Tata
Christopher Sondey
Kristine Devito
James Fossetta
Charles G. Garlisi
Daniel Lundell
Xiaoda Niu
Show All
Source
Cite
Save
Citations (10)
Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors.
2015
ACS Medicinal Chemistry Letters
William Michael Seganish
Thierry O. Fischmann
Brad Sherborne
Julius J. Matasi
Brian J. Lavey
William T. McElroy
Deen Tulshian
Jim Tata
Christopher Sondey
Charles G. Garlisi
Kristine Devito
James Fossetta
Daniel Lundell
Xiaoda Niu
Show All
Source
Cite
Save
Citations (16)
Inhibiteurs de kinases associées aux récepteurs d'interleukine à base d'amidopyrazole
2012
William T. McElroy
Guoqing Li
Ginny D. Ho
Zheng Tan
Sunil Paliwal
William Michael Seganish
Deen Tulshian
John W. Lampe
Joey L. Methot
Hua Zhou
Michael D. Altman
Liang Zhu
Show All
Source
Cite
Save
Citations (0)
Dérivés de dihydroimidazoisoquinoléine utiles en tant qu'inhibiteurs de pde10
2010
Ginny D. Ho
William Michael Seganish
Deen Tulshian
Cornelis Marius Timmers
Rachel Deborah Van Rijn
Hubert Jan Jozef Loozen
Show All
Source
Cite
Save
Citations (0)
1